View the KEFUCLAV 250 registration information details.
Back to drug list
ItemsDrug Registration information
ID2849
No2849
Brand NameKEFUCLAV 250
IngredientsCEFUROXIME AXETIL USP 312.5 MG EQ.TO CEFUROXIME 250 MG, DILUTED POTASSIUM CLAVULANATE( WITH AVICEL) BP 148.81 MG EQ.TO CLAVULANIC ACID 62.5 MG
Dosage FormFILM-COATED TABLETS
Primary PackagingALU-ALU STRIP
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 2 X 7'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsPHARYNGITIS/TONSILLITIS, ACUTE BACTERIAL OTITIS MEDIA, ACUTE BACTERIAL MAXILLARY SINUSITIS, ACUTE BACTERIAL EXACERBATIONS OF CHRONIC BRONCHITIS AND SECONDARY BACTERIAL INFECTIONS OF ACUTE BRONCHITIS, UNCOMPLICATED SKIN AND SKIN-STRUCTURE INFECTIONS, UNCOMPLICATED URINARY TRACT INFECTION, UNCOMPLICATED GONORRHEA.
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionLIGHT YELLOW TO YELLOW CAPLET SHAPE, DEEP BICONVEX FILM COATED TABLET, ONE SCORE ON ONE SIDE
Note
License OwnerVIMPEX (LAO) CO.,LTD
ManufacturerESKAYEF PHARMACEUTICALS LIMITED
CountryBANGLADESH
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No07 I 4523/18
FDD Registration Date07/07/2025
Expiry Date06/07/2030
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA